Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis

Tofacitinib, a novel Janus kinase inhibitor, may prevent structural damage in rheumatoid arthritis (RA). In this cohort study, we compared radiographic progression of hand joints between 21 RA patients who took tofacitinb for 18 months in a phase IIb and its extension study and 42 patients who took...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joon Wan, Choi, In Ah, Lee, Eun Young, Song, Yeong Wook, Lee, Eun Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744699/
https://www.ncbi.nlm.nih.gov/pubmed/23960438
http://dx.doi.org/10.3346/jkms.2013.28.8.1134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744699/
https://www.ncbi.nlm.nih.gov/pubmed/23960438
http://dx.doi.org/10.3346/jkms.2013.28.8.1134

Ejemplares similares